Side-effects of cidofovir in the treatment of recurrent respiratory papillomatosis

European Archives of Oto-Rhino-Laryngology

Volumn 265, Issue 8, 2008, Pages 871-879

  Broekema, Ferdinand I ^a   Dikkers, Frederik G ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Cidofovir; Larynx; Papilloma; Recurrent respiratory papillomatosis; Side effects

Indexed keywords

CIDOFOVIR; INTERFERON;

ADULT; ALOPECIA; CARCINOGENICITY; CONTROLLED STUDY; DYSPLASIA; EPIGLOTTITIS; FEMALE; FIBROSIS; HUMAN; INCIDENCE; INFLAMMATION; LARYNX DISORDER; LEUKOPENIA; MAJOR CLINICAL STUDY; MALE; PAPILLOMATOSIS; PRECORDIAL PAIN; PRIORITY JOURNAL; RASH; RECURRENT RESPIRATORY PAPILLOMATOSIS; REVIEW; RISK FACTOR; SCAR FORMATION;

ADOLESCENT; ADULT; ANIMALS; ANTINEOPLASTIC AGENTS; CHILD; CYTOSINE; FEMALE; HUMANS; INJECTIONS, INTRALESIONAL; LARYNGEAL NEOPLASMS; MALE; NEOPLASM RECURRENCE, LOCAL; PAPILLOMA; PHOSPHONIC ACIDS;

EID: 45849099448     PISSN: 09374477     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00405-008-0658-0     Document Type: Review

References (56)

1. Akst LM, Lee W, Discolo C, Knott D, Younes A, Koltai PJ (2003) Stepped-dose protocol of cidofovir therapy in recurrent respiratory papillomatosis in children. Arch Otolaryngol Head Neck Surg 129:841-846
2. Armbruster C, Kreuzer A, Vorbach H, Huber M, Armbruster C (2001) Successful treatment of severe respiratory papillomatosis with intravenous cidofovir and interferon alpha-2b. Eur Respir J 17:830-831
3. Askew J, Black R (2005) Intralesional cidofovir use in recurrent respiratory papillomatosis of childhood. Aust J Otolaryng 8:26-29
4. Avelino M, Gutzman R, Fujita R, Pignatari S, Weckx L, Pontes P (2004) Cidofovir effects on recurrent laryngeal papillomatosis in children: preliminary report. Rev Bras Otorrinolaringol 70:734-738
5. Bauman NM, Smith RJ (1996) Recurrent respiratory papillomatosis. Pediatr Clin North Am 43:1385-1401
6. Bielamowicz S, Villagomez V, Stager SV, Wilson WR (2002) Intralesional cidofovir therapy for laryngeal papilloma in an adult cohort. Laryngoscope 112:696-699
7. Bila V, Otova B, Jelinek R, Sladka M, Mejsnarova B, Holy A, Kren V (1993) Antimitotic and teratogenic effects of acyclic nucleotide analogues 1-(S)-(3-hydroxy-2-phosphonomethoxyethyl)cytosine (HPMPC) and 9-(2-phosphonomethoxyethyl) adenine (PMEA). Folia Biol (Praha) 39:150-161
8. Byrne JC, Tsao MS, Fraser RS, Howley PM (1987) Human papillomavirus-11 DNA in a patient with chronic laryngotracheobronchial papillomatosis and metastatic squamous-cell carcinoma of the lung. N Engl J Med 317:873-878
9. Chhetri DK, Blumin JH, Shapiro NL, Berke GS (2002) Office-based treatment of laryngeal papillomatosis with percutaneous injection of cidofovir. Otolaryngol Head Neck Surg 126:642-648
10. Chhetri DK, Jahan-Parwar B, Hart SD, Bhuta SM, Berke GS, Shapiro NL (2003) Local and systemic effects of intralaryngeal injection of cidofovir in a canine model. Laryngoscope 113:1922-1926
11. Chhetri DK, Shapiro NL (2003) A scheduled protocol for the treatment of juvenile recurrent respiratory papillomatosis with intralesional cidofovir. Arch Otolaryngol Head Neck Surg 129:1081-1085
12. Chung BJ, Akst LM, Koltai PJ (2006) 3.5-Year follow-up of intralesional cidofovir protocol for pediatric recurrent respiratory papillomatosis. Int J Pediatr Otorhinolaryngol 70:1911-1917
13. Co J, Woo P (2004) Serial office-based intralesional injection of cidofovir in adult-onset recurrent respiratory papillomatosis. Ann Otol Rhinol Laryngol 113:859-862
14. Coulombeau B, Nusa NA, Ceruse P, Froehlich P (2002) [Anti-viral injectable treatment (cidofovir) in laryngeal papillomatosis]. Rev Laryngol Otol Rhinol (Bord) 123:315-320
15. Cundy KC (1999) Clinical pharmacokinetics of the antiviral nucleotide analogues cidofovir and adefovir. Clin Pharmacokinet 36:127-143
16. Dallimore NS (1985) Squamous bronchial carcinoma arising in a case of multiple juvenile papillomatosis. Thorax 40:797-798
17. Dancey DR, Chamberlain DW, Krajden M, Palefsky J, Alberti PW, Downey GP (2000) Successful treatment of juvenile laryngeal papillomatosis-related multicystic lung disease with cidofovir: case report and review of the literature. Chest 118:1210-1214
18. de Bilderling G, Bodart E, Lawson G, Tuerlinckx D, Remacle M, Naesens L, De Clercq E, Snoeck R (2005) Successful use of intralesional and intravenous cidofovir in association with indole-3-carbinol in an 8-year-old girl with pulmonary papillomatosis. J Med Virol 75:332-335
19. Derkay C (2005) Cidofovir for recurrent respiratory papillomatosis (RRP): a re-assessment of risks. Int J Pediatr Otorhinolaryngol 69:1465-1467
20. Dikkers FG (2006) Treatment of recurrent respiratory papillomatosis with microsurgery in combination with intralesional cidofovir-a prospective study. Eur Arch Otorhinolaryngol 263:440-443
21. El Aatmani M, Steinmetz A, Debry D, Levêque D, Koffel J-C, Beretz L (2002) À propos d'un cas de traitement de la papillomatose laryngée récidivante par injections intralésionnelles de cidofovir (Vistide). J Pharm Clin 21:287-290
22. El Hakim H, Waddell AN, Crysdale WS (2002) Observations on the early results of treatment of recurrent respiratory papillomatosis using cidofovir. J Otolaryngol 31:333-335
23. Food and Drug Administration. http://www.fda.gov/cder/handbook/categc.htm
24. Food and Drug Administration. 1996 http://www.fda.gov/cder/foi/adcomm/96/ avdac_joint_031496_summmin_ac.pdf
25. Gilead Sciences. Inc. 2000 Vistide (cidofovir) package insert. Foster City, CA
26. Giles BL, Seifert B (2006) CR12/339-Nebulized cidofovir for recurrent respiratory papillomatosis: a case report. Paediatr Respir Rev 7(Suppl 1):S330
27. Guillou L, Sahli R, Chaubert P, Monnier P, Cuttat JF, Costa J (1991) Squamous cell carcinoma of the lung in a nonsmoking, nonirradiated patient with juvenile laryngotracheal papillomatosis. Evidence of human papillomavirus-11 DNA in both carcinoma and papillomas. Am J Surg Pathol 15:891-898
28. Hoffman VF, Skiest DJ (2000) Therapeutic developments in cytomegalovirus retinitis. Expert Opin Investig Drugs 9:207-220
29. Kimberlin DW (2004) Current status of antiviral therapy for juvenile-onset recurrent respiratory papillomatosis. Antiviral Res 63:141-151
30. Lee AS, Rosen CA (2004) Efficacy of cidofovir injection for the treatment of recurrent respiratory papillomatosis. J Voice 18:551-556
31. Lindeberg H, Syrjanen S, Karja J, Syrjanen K (1989) Human papillomavirus type 11 DNA in squamous cell carcinomas and pre-existing multiple laryngeal papillomas. Acta Otolaryngol 107:141-149
32. Mandell DL, Arjmand EM, Kay DJ, Casselbrant ML, Rosen CA (2004) Intralesional cidofovir for pediatric recurrent respiratory papillomatosis. Arch Otolaryngol Head Neck Surg 130:1319-1323
33. Milczuk HA (2003) Intralesional cidofovir for the treatment of severe juvenile recurrent respiratory papillomatosis: long-term results in 4 children. Otolaryngol Head Neck Surg 128:788-794
34. Moore CE, Wiatrak BJ, McClatchey KD, Koopmann CF, Thomas GR, Bradford CR, Carey TE (1999) High-risk human papillomavirus types and squamous cell carcinoma in patients with respiratory papillomas. Otolaryngol Head Neck Surg 120:698-705
35. Naiman AN, Abedipour D, Ayari S, Fresnel E, Coulombeau B, Bour JB, Froehlich P (2006) Natural history of adult-onset laryngeal papillomatosis following multiple cidofovir injections. Ann Otol Rhinol Laryngol 115:175-181
36. Naiman AN, Ayari S, Nicollas R, Landry G, Coulombeau B, Froehlich P (2006) Intermediate-term and long-term results after treatment by cidofovir and excision in juvenile laryngeal papillomatosis. Ann Otol Rhinol Laryngol 115:667-672
37. Naiman AN, Ceruse P, Coulombeau B, Froehlich P (2003) Intralesional cidofovir and surgical excision for laryngeal papillomatosis. Laryngoscope 113:2174-2181
38. Naiman AN, Roger G, Gagnieu MC, Bordenave J, Mathaut S, Ayari S, Nicollas R, Bour JB, Garabedian N, Froehlich P (2004) Cidofovir plasma assays after local injection in respiratory papillomatosis. Laryngoscope 114:1151-1156
39. Neumann K, Pudszuhn A, Welzel C, Bartel-Friedrich S, Passmann M (2003) [Intralesional cidofovir injections for recurrent laryngeal papillomatosis: first results]. Laryngorhinootologie 82:700-706
40. Palomar AV, Palomar GV, Soteras OJ, Ruiz GA (2005) [Cidofovir activity in infantile recurrent respiratory papillomatosis]. Acta Otorrinolaringol Esp 56:22-24
41. Petersen BL, Buchwald C, Gerstoft J, Bretlau P, Lindeberg H (1998) An aggressive and invasive growth of juvenile papillomas involving the total respiratory tract. J Laryngol Otol 112:1101-1104
42. Peyton SW, Wiatrak B (2004) Is cidofovir a useful adjunctive therapy for recurrent respiratory papillomatosis in children? Int J Pediatr Otorhinolaryngol 68:413-418
43. Pontes P, Avelino M, Pignatari S, Weckx LL (2006) Effect of local application of cidofovir on the control of recurrences in recurrent laryngeal papillomatosis. Otolaryngol Head Neck Surg 135:22-27
44. Pou AM, Rimell FL, Jordan JA, Shoemaker DL, Johnson JT, Barua P, Post JC, Ehrlich GD (1995) Adult respiratory papillomatosis: human papillomavirus type and viral coinfections as predictors of prognosis. Ann Otol Rhinol Laryngol 104:758-762
45. Pransky SM, Albright JT, Magit AE (2003) Long-term follow-up of pediatric recurrent respiratory papillomatosis managed with intralesional cidofovir. Laryngoscope 113:1583-1587
46. Pransky SM, Brewster DF, Magit AE, Kearns DB (2000) Clinical update on 10 children treated with intralesional cidofovir injections for severe recurrent respiratory papillomatosis. Arch Otolaryngol Head Neck Surg 126:1239-1243
47. Pransky SM, Magit AE, Kearns DB, Kang DR, Duncan NO (1999) Intralesional cidofovir for recurrent respiratory papillomatosis in children. Arch Otolaryngol Head Neck Surg 125:1143-1148
48. Pudszuhn A, Welzel C, Bloching M, Neumann K (2007) Intralesional Cidofovir application in recurrent laryngeal papillomatosis. Eur Arch Otorhinolaryngol 264:63-70
49. Rady PL, Schnadig VJ, Weiss RL, Hughes TK, Tyring SK (1998) Malignant transformation of recurrent respiratory papillomatosis associated with integrated human papillomavirus type 11 DNA and mutation of p53. Laryngoscope 108:735-740
50. Sheahan P, Sexton S, Russell JD (2006) Is intralesional cidofovir worthwhile in juvenile recurrent respiratory papillomatosis? J Laryngol Otol 120:561-565
51. Snoeck R, Wellens W, Desloovere C, Van Ranst M, Naesens L, De Clercq E, Feenstra L (1998) Treatment of severe laryngeal papillomatosis with intralesional injections of cidofovir [(S)-1-(3-hydroxy-2- phosphonylmethoxypropyl)cytosine]. J Med Virol 54:219-225
52. Spiegel JH, Andrus JG, Stefanato CM, Heeren T (2005) Histopathologic effects of cidofovir on cartilage. Otolaryngol Head Neck Surg 133:666-671
53. Van Valckenborgh I, Wellens W, De Boeck K, Snoeck R, De Clercq E, Feenstra L (2001) Systemic cidofovir in papillomatosis. Clin Infect Dis 32:E62-E64
54. Wachsman M, Petty BG, Cundy KC, Jaffe HS, Fisher PE, Pastelak A, Lietman PS (1996) Pharmacokinetics, safety and bioavailability of HPMPC (cidofovir) in human immunodeficiency virus-infected subjects. Antiviral Res 29:153-161
55. Wemer RD, Lee JH, Hoffman HT, Robinson RA, Smith RJ (2005) Case of progressive dysplasia concomitant with intralesional cidofovir administration for recurrent respiratory papillomatosis. Ann Otol Rhinol Laryngol 114:836-839
56. Wilson WR, Hashemiyoon R, Hawrych A (2000) Intralesional cidofovir for recurrent laryngeal papillomas: preliminary report. Ear Nose Throat J 79:236-238, 240